Fever in the Infant and Toddler
- Author: Jane M Gould, MD, FAAP; Chief Editor: Russell W Steele, MD more...
Background
Fever in the infant and toddler is one of the most common problems and greatest challenges faced by those caring for them. This article addresses the most common etiologies of fever in these age groups and the appropriate clinical prediction rules for identifying infants and toddlers at lowest risk for serious bacterial infections. (See also Fever Without a Focus and Emergent Management of Pediatric Patients With Fever.)
Neonates
Neonates with fever who are aged 28 days or younger may have few clues on history and physical examination to guide therapy. Therefore, a high index of suspicion is necessary in order to detect the febrile neonate with a serious bacterial infection. Obtaining the pertinent medical history from the mother regarding the pregnancy, delivery, and early neonatal life of the febrile neonate is essential. Typically, infections that occur in the first week of life are secondary to vertical transmission, and those infections occurring after the first week are usually community acquired or hospital acquired.
Definitive identification of a serious bacterial infection requires laboratory investigation; a full sepsis evaluation; and a positive result in blood culture, cerebrospinal fluid (CSF), and/or urine. Bacterial meningitis is more common in the first month of life than at any other time. An estimated 5-10% of neonates with early onset group B streptococcal (GBS) sepsis have concurrent meningitis.[1]
Young Infants
The general approach to fever in a febrile infant aged 28-60 days includes maintaining a high index of suspicion, because these patients often lack clues on physical examination. The prevalence of a serious bacterial infection in an infant younger than 3 months is approximately 6-10%. Interestingly, infants aged 3 months or younger with a confirmed viral infection are at lower risk for a serious bacterial infection when compared with those in whom a viral infection is not identified[2] ; although a urinary tract infection (UTI) is still a significant concurrent infection in infants with bronchiolitis.
Children Aged 2 Months to 3 Years
According to guidelines from the Agency of Health Care Policy and Research, in infants younger than 3 months with rectal temperatures 38o C or higher, the incidence of serious bacterial infection is 6-10%, with a 1-2% incidence of bacteremia, meningitis, or both.[3]
Historically, children aged 3 months to 3 years with rectal temperatures of 38.5o C or higher had a risk of 2-4% for occult bacteremia.[3, 4] The leading cause of bloodstream infection was Streptococcus pneumoniae, followed by Haemophilus influenzae type b. With the introduction of effective vaccines for these pathogens, the incidence and epidemiology of childhood bacteremia in the immunologically normal host has changed.[5, 6]
The incidence of occult bacteremia in this population now ranges from 0.5-1%; moreover, 2 of every 3 blood isolates from these children represent an artifact (contamination) and not a true pathogen.[5]S pneumoniae and Escherichia coli are the most common pathogens, accounting for two thirds of cases. In infants with S pneumoniae, many isolates are strains not covered by the currently available heptavalent conjugate vaccine.
Children with pneumococcal bacteremia may present with acute otitis media, pneumonia, symptoms of sinusitis, meningitis, febrile seizures, cellulitis (including orbital or facial cellulitis), or nonspecific febrile illnesses. E coli bacteremia is most common in children younger than 1 year and is usually associated with urinary tract infection (UTI). Staphylococcus aureus accounts for 15% of bloodstream infections and may be associated with skin, soft tissues, or musculoskeletal infections. Salmonella species, Neisseria meningitides, and S pyogenes account for most of the remaining infections.
As with most patients, the approach to the febrile child aged 3 months to 3 years consists of a targeted medical history, a complete physical examination, and the judicious use of the laboratory tests.
Edwards MS, Nizet V, Baker CJ. Group B streptococcal infections. In: Remington JS, Klein JO, Wilson CB, Baker CJ, eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, Pa: Elsevier Saunders; 2006:403.
Byington CL, Enriquez FR, Hoff C, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics. Jun 2004;113(6):1662-6. [Medline].
McGowan JE Jr, Bratton L, Klein JO, Finland M. Bacteremia in febrile children seen in a "walk-in" pediatric clinic. N Engl J Med. Jun 21 1973;288(25):1309-12. [Medline].
Teele DW, Pelton SI, Grant MJ, et al. Bacteremia in febrile children under 2 years of age: results of cultures of blood of 600 consecutive febrile children seen in a "walk-in" clinic. J Pediatr. Aug 1975;87(2):227-30. [Medline].
Herz AM, Greenhow TL, Alcantara J, et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J. Apr 2006;25(4):293-300. [Medline].
Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. Jul 1993;22(7):1198-210. [Medline].
Bonsu BK, Harper MB. Leukocyte counts in urine reflect the risk of concomitant sepsis in bacteriuric infants: a retrospective cohort study. BMC Pediatr. Jun 13 2007;7:24. [Medline]. [Full Text].
Jaskiewicz JA, McCarthy CA, Richardson AC, et al. Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics. Sep 1994;94(3):390-6. [Medline].
Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics. Aug 2001;108(2):311-6. [Medline].
Meehan WP 3rd, Bachur RG. Predictors of cerebrospinal fluid pleocytosis in febrile infants aged 0 to 90 days. Pediatr Emerg Care. May 2008;24(5):287-93. [Medline].
Kuppermann N, Fleisher GR, Jaffe DM. Predictors of occult pneumococcal bacteremia in young febrile children. Ann Emerg Med. Jun 1998;31(6):679-87. [Medline].
Hoberman A, Wald ER, Reynolds EA, Penchansky L, Charron M. Is urine culture necessary to rule out urinary tract infection in young febrile children?. Pediatr Infect Dis J. Apr 1996;15(4):304-9. [Medline].
Bleeker SE, Derksen-Lubsen G, Grobbee DE, Donders AR, Moons KG, Moll HA. Validating and updating a prediction rule for serious bacterial infection in patients with fever without source. Acta Paediatr. Jan 2007;96(1):100-4. [Medline].
Isaacman DJ, Shults J, Gross TK, Davis PH, Harper M. Predictors of bacteremia in febrile children 3 to 36 months of age. Pediatrics. Nov 2000;106(5):977-82. [Medline].
Lacour AG, Zamora SA, Gervaix A. A score identifying serious bacterial infections in children with fever without source. Pediatr Infect Dis J. Jul 2008;27(7):654-6. [Medline].
Baraff LJ. Management of infants and young children with fever without source. Pediatr Ann. Oct 2008;37(10):673-9. [Medline].
Hay AD, Costelloe C, Redmond NM, et al. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ. Sep 2 2008;337:a1302. [Medline].
Harper MB, Bachur R, Fleisher GR. Effect of antibiotic therapy on the outcome of outpatients with unsuspected bacteremia. Pediatr Infect Dis J. Sep 1995;14(9):760-7. [Medline].

